Generics Global Group of Eight (G8) Industry Guide 2019-2028


Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Key Highlights

  • The G8 countries contributed $1,61,715.9 million in 2023 to the global generics industry, with a compound annual growth rate (CAGR) of 5.8% between 2019 and 2023. The G8 countries are expected to reach a value of $2,15,698.2 million in 2028, with a CAGR of 5.9% over the 2023-28 period.
  • Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $74,229.0 million in 2023. This was followed by Germany and the UK, with a value of $27,662.3 and $15,516.9 million, respectively.
  • The US is expected to lead the generics industry in the G8 nations with a value of $98,531.3 million in 2016, followed by Germany and the UK with expected values of $33,345.6 and $23,397.0 million, respectively.




Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market
  • Leading company profiles reveal details of key generics market players’ G8 operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume
  • Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country




Reasons To Buy

  • What was the size of the G8 generics market by value in 2023?
  • What will be the size of the G8 generics market in 2028?
  • What factors are affecting the strength of competition in the G8 generics market?
  • How has the market performed over the last five years?
  • How large is the G8 generics market in relation to its regional counterparts?